ZIM Laboratories informs about press release

21 Jul 2025 Evaluate
ZIM Laboratories has informed that it enclosed the Press Release relating to grant of Marketing Authorization for ‘Rizatriptan Benzoate Orally Disintegrating Strips’ in Australia by the Therapeutic Goods Administration (TGA), to ZIMTAS PTY LTD. (‘ZIMTAS’), Subsidiary of the company.

The above information is a part of company’s filings submitted to BSE. 

Zim Laboratories Share Price

68.61 -1.59 (-2.26%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×